Overview

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Status:
Recruiting

Trial end date:
2022-10-31

Target enrollment:

Participant gender:

Summary

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 30 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

University of Wisconsin, Madison

Collaborator:

Veloxis Pharmaceuticals

Treatments:

Pancrelipase
Tacrolimus